[Federal Register Volume 60, Number 19 (Monday, January 30, 1995)]
[Notices]
[Pages 5687-5688]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-2146]



-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

Recombinant DNA Advisory Committee; Meeting

    Pursuant to Public Law 92-463, notice is hereby given of a meeting 
of the Recombinant DNA Advisory Committee on March 6-7, 1995. The 
meeting will be held at the National Institutes of Health, Building 
31C, 6th Floor, Conference Room 6, 9000 Rockville Pike, Bethesda, 
Maryland 20892, starting on March 6, 1995, at approximately 9 a.m., and 
will recess at approximately 6 p.m. The meeting will reconvene on March 
7, 1995, at approximately 8:30 a.m. and will adjourn at approximately 5 
p.m. The meeting will be open to the public to discuss Proposed Actions 
under the NIH Guidelines for Research Involving Recombinant DNA 
Molecules (59 FR 34496) and other matters to be considered by the 
Committee. The Proposed Actions to be discussed will follow this notice 
of meeting. Attendance by the public will be limited to space 
available. Members of the public wishing to speak at this meeting 
[[Page 5688]] may be given such opportunity at the discretion of the 
Chair.
    Dr. Nelson A. Wivel, Director, Office of Recombinant DNA 
Activities, Suite 323, National Institutes of Health, 6006 Executive 
Boulevard, MSC 7052, Bethesda, Maryland 20892-7052, Phone (301) 496-
9838, FAX (301) 496-9839, will provide materials to be discussed at 
this meeting, roster of committee members, and substantive program 
information. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should contact Dr. Wivel in advance of the meeting. A 
summary of the meeting will be available at a later date.
    OMB's ``Mandatory Information Requirements for Federal Assistance 
Program Announcements'' (45 FR 39592, June 11, 1980) requires a 
statement concerning the official government programs contained in the 
Catalog of Federal Domestic Assistance. Normally NIH lists in its 
announcements the number and title of affected individual programs for 
the guidance of the public. Because the guidance in this notice covers 
not only virtually every NIH program but also essentially every Federal 
research program in which DNA recombinant molecule techniques could be 
used, it has been determined not to be cost effective or in the public 
interest to attempt to list these programs. Such a list would likely 
require several additional pages. In addition, NIH could not be certain 
that every Federal program would be included as many Federal agencies, 
as well as private organizations, both national and international, have 
elected to follow the NIH Guidelines. In lieu of the individual program 
listing, NIH invites readers to direct questions to the information 
address above about whether individual programs listed in the Catalog 
of Federal Domestic Assistance area affected.

    Dated: January 23, 1995.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 95-2146 Filed 1-27-95; 8:45 am]
BILLING CODE 4140-01-M